Metreleptin/Pramlintide Acetate

醋酸普兰林肽/美曲普汀

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMetreleptin/Pramlintide Acetate
Drug Alias Name美曲普汀+醋酸普兰林肽metreleptin+pramlintidePramlintide Acetate/Metreleptin醋酸普兰林肽+美曲普汀Metreleptin+Pramlintide Acetate +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionLeptin receptor agonistsCalcitonin receptor agonists
TargetsLeptin receptorCalcitonin receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Pramlintide acetateMetreleptin
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmylin Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmylin PharmaceuticalTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A